$14.26-0.20 (-1.38%)
Sally Beauty Holdings, Inc.
Sally Beauty Holdings, Inc. in the Consumer Cyclical sector is trading at $14.26 with a market capitalization of $1.2B. Wall Street consensus targets $16.40 (5 analysts), implying a +15.0% move over the next 12 months. The stock is currently 20% below its 52-week high of $17.92, remaining 2.8% below its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $903.38M↓ | $943.17M↓ | $947.08M↑ | $933.31M↑ | $883.15M |
| Gross Profit | $475.77M↓ | $483.26M↓ | $494.11M↑ | $480.99M↑ | $458.82M |
| Operating Income | $71.93M↓ | $75.94M↓ | $79.94M↑ | $78.17M↑ | $69.37M |
| Net Income | $42.70M↓ | $45.56M↓ | $49.93M↑ | $45.72M↑ | $39.21M |
Sally Beauty Holdings, Inc. operates as a specialty retailer and distributor of professional beauty supplies. The company operates through two segments, Sally Beauty Supply and Beauty Systems Group. The Sally Beauty Supply segment offers beauty produ...
ULTA faces macro and competitive pressures, but loyalty growth, AI initiatives and international expansion continue supporting performance.
A number of stocks jumped in the afternoon session after sentiment in the retail space improved as monthly retail sales rose a healthy 0.9% month-over-month and 6.9% year-over-year per the Census Bureau.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
Sally Beauty (SBH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
ULTA posts strong Q1 growth as broad-based category momentum and fragrance strength drive sales gains and support 2026 guidance.